While the recent phase 3 trial for orforglipron was specifically for type 2 diabetes and not weight loss, the study found that patients who took the drug lost considerable weight
With OrderlyMeds, you dont have to go it alone
Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study
Giridhar-Gohal, who has spent the last 25 years working in FMCG and retail with global corporations such as Diageo and PepsiCo, says there are opportunities for companies that can develop products that deliver high nutritional value in smaller formats, such as protein-forward snacks, fibre-rich foods that support satiety, portion-controlled products, and nutrient-dense mini-meals or functional beverages
The Cholesterol Myths: Exposing the Fallacy that Saturated Fat and Cholesterol Cause Heart Disease [Uffe Ravnskov] on Amazon.com
Visceral (deep belly) fat often shrinks faster than other fat